Search

everythinglearnresearchcommunity

for

Search:↓

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

A high fiber, low glycemic diet, exercise, and stress management can help reduce PCOS symptoms.

PCOS is a complex disorder needing lifestyle changes, support, and treatment, with new herbal treatments showing promise.

PSA can help diagnose high androgen levels in women.

Ginger may help reduce testosterone and improve menstrual issues in women with PCOS.

The most common form of PCOS in the group was anovulatory PCOS, with no cases of obese PCOS, highlighting the importance of assessing lean women with menstrual issues.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Androgenetic alopecia is the most common hair loss in females with PCOS in Egypt.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Using a combined treatment of minoxidil and metformin can improve hair loss in women by normalizing hormone and metabolism levels.

More research is needed to confirm if vitamin D helps improve pregnancy rates in women with hyperandrogenic PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

An ovarian tumor can cause high male hormones in postmenopausal women.